DYN Shares Outstanding History



Below is a table of the DYN shares outstanding history going back to 9/17/2020:

Date DYN Shares Outstanding
9/17/202041.63M
10/31/202045.45M
2/26/202151.46M
4/30/202151.21M
7/31/202151.28M
10/31/202151.53M
2/28/202251.64M
4/30/202251.65M
7/31/202251.77M
10/31/202252.13M
2/28/202356.34M
4/30/202358.31M
7/31/202361.02M
10/27/202361.38M
2/29/202481.96M
4/30/202487.38M
8/9/2024100.40M

Also see: DYN Market Cap History
DYN YTD Return
DYN Historical Shares Outstanding:
+25.35% CAGR
DYN Historical Shares Outstanding: +25.35% CAGR

Mouse over chart for data details
9/17/2020 ...8/9/2024
Dyne Therapeutics is a muscle disease company focused on developing therapeutics for people living with genetically driven diseases. Co. is developing the following product candidates: DYNE-101, to address the genetic basis of myotonic dystrophy type 1 by targeting the toxic nuclear DMPK RNA that causes the disease; DYNE-251 for patients with mutations amenable to skipping Exon 51, to be followed by the development of therapeutics for patients with mutations amenable to skipping other exons, including Exon 53, 45 and 44; and DYNE-301 to address the genetic basis of facioscapulohumeral dystrophy by reducing DUX4 expression in muscle tissue. We show 17 historical shares outstanding datapoints in our coverage of DYN's shares outstanding history.

Understanding the changing numbers of DYN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DYN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DYN by allowing them to research DYN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree DYN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dyne Therapeutics (DYN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

DYNT Shares Outstanding History
EAR Shares Outstanding History
EBS Shares Outstanding History
ECOR Shares Outstanding History
ECYT Shares Outstanding History
EDAP Shares Outstanding History
EDGE Shares Outstanding History
EDIT Shares Outstanding History
EGLT Shares Outstanding History
EGRX Shares Outstanding History
More Healthcare companies »

 

DYN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.